MENA emerging as trial destination says ClinTec CEO

MENA emerging as trial destination says ClinTec CEO

5 Minuten

Beschreibung

vor 15 Jahren
Improving healthcare infrastructure across the region and a large
treatment-naïve patient population makes the Middle East and North
Africa (MENA) an increasingly attractive destination for drug
trials says ClinTec CEO Rabinder Buttar.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15